WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999039006) METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/039006    International Application No.:    PCT/US1999/001964
Publication Date: 05.08.1999 International Filing Date: 29.01.1999
Chapter 2 Demand Filed:    11.08.1999    
IPC:
C12N 15/10 (2006.01), C12Q 1/68 (2006.01)
Applicants: GENOPLEX, INC. [US/US]; 6840 N. Broadway Denver, CO 80221 (US) (For All Designated States Except US).
SIKELA, James, M. [US/US]; (US) (For US Only).
MESSIER, Walter [US/US]; (US) (For US Only)
Inventors: SIKELA, James, M.; (US).
MESSIER, Walter; (US)
Agent: SWANSON, Barry, J.; Swanson & Bratschun, L.L.C. Suite 330 1745 Shea Center Drive Highlands Ranch, CO 80126 (US)
Priority Data:
60/073,263 30.01.1998 US
Title (EN) METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS
(FR) TECHNIQUES D'IDENTIFICATION DE SEQUENCES DE POLYNUCLEOTIDES ET DE POLYPEPTIDES POUVANT ETRE ASSOCIEES A DES ETATS PHYSIOLOGIQUES ET MEDICAUX
Abstract: front page image
(EN)The present invention provides methods for identifying polynucleotide and polypeptide sequences in human and/or non-human primates which may be associated with a physiological condition, such as disease (including susceptibility (human) or resistance (chimpanzee) to development of AIDS). The methods employ comparison of human and non-human primate sequences using statistical methods. Sequences thus identified may be useful as host therapeutic targets and/or in screening assays.
(FR)La présente invention concerne des techniques d'identification de séquences de polynucléotides et de polypeptides chez l'homme et/ou chez les autres primates qui peuvent être associées à un état physiologique, tel que la maladie (y compris la vulnérabilité (humaine) ou la résistance (chimpanzé) au développement du SIDA). Les techniques consistent à comparer entre elles les séquences humaines et celles des autres primates, à l'aide de méthodes statistiques. On peut se servir des séquences identifiées comme cibles thérapeutiques hôtes et/ou dans les analyses de criblage.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)